Otherwise, an additional investigation into enhanced tumor immunity, which leads to the inhibition of immune evasion and cancer aggressiveness, by suppressing the up-regulated expression of PD-L1 via the reduced activation of STAT1/STAT3 signaling, is worth pursuing in oral cancer cell lines. The gene discussed is STAT3; the disease is neoplasm.